Literature DB >> 6300203

Initial experience with nuclear magnetic resonance (NMR) imaging of the human breast.

S J El Yousef, R J Alfidi, R H Duchesneau, C A Hubay, J R Haaga, P J Bryan, J P LiPuma, A E Ament.   

Abstract

Two patients with breast abnormalities, one malignant and one benign, were studied with nuclear magnetic resonance (NMR) imaging utilizing a cryogenic superconducting magnet. Three-dimensional NMR images were obtained in one case and single slice planar images were obtained in the other. The NMR images correlated well with the corresponding mammograms. Although both conditions exhibited a different signal intensity for the area of abnormality compared to adjacent ductal and fatty tissue, the configuration of the abnormal areas allowed distinction between benign and malignant process.

Entities:  

Mesh:

Year:  1983        PMID: 6300203     DOI: 10.1097/00004728-198304000-00001

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  4 in total

1.  Combination of low and high resolution sequences in two orientations for dynamic contrast-enhanced MRI of the breast: more than a compromise.

Authors:  Toni W Vomweg; Andrea Teifke; R Peter Kunz; Christian Hintze; Alexander Hlawatsch; Annett Kern; Karl F Kreitner; Manfred Thelen
Journal:  Eur Radiol       Date:  2004-07-29       Impact factor: 5.315

2.  Magnetic resonance imaging of the breast: functional T1 and three-dimensional imaging.

Authors:  C L Partain; M V Kulkarni; R R Price; A C Fleischer; D L Page; A W Malcolm; A C Winfield; A E James
Journal:  Cardiovasc Intervent Radiol       Date:  1986       Impact factor: 2.740

3.  The periodic health examination: 3. Breast cancer.

Authors:  B Morrison
Journal:  CMAJ       Date:  1986-04-01       Impact factor: 8.262

Review 4.  Breast cancer imaging: a perspective for the next decade.

Authors:  Andrew Karellas; Srinivasan Vedantham
Journal:  Med Phys       Date:  2008-11       Impact factor: 4.071

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.